Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Moog Inc.
The global infusion drug delivery market continues to be driven by the rising prevalence of chronic disease and associated obesity, coupled with a growing aging population. Technological advancements such as less invasive pumps, needlestick prevention features and miniaturization have also supported the growing demand, but obstacles such as safety and security issues remain. According to a new report by Meddevicetracker, the global market for infusion pumps and disposables will reach $9.9bn by 2022, a CAGR of 6.4% from 2017. This article takes an in-depth look at the overall infusion pumps market, and dives deeper into the three fastest-growing segments – insulin, enteral and disposable pumps – highlighting the key players and competitive landscape.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, Alliance, and Financing activity.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.
StnDrd Infusion Inc.’s StnDrd Infusion Therapy System streamlines general-purpose infusion pumps by combining within one device the ability to effectively and safely infuse all three classifications of infusion: large volume, syringe and ambulatory. The StnDrd Infusion technology allows for multiple drug channels and multiple therapies. It can deliver up to four drugs simultaneously or sequentially down a single line into the patient, and it can also follow the patient from the operating room to the intensive care unit to general recovery.
- Medical Devices